How to Choose Research-Grade TB-500 in Canada: A Supplier Checklist for Laboratories

BUYING GUIDE · TB-500 · CANADA

How to Choose Research-Grade TB-500 in Canada: A Supplier Checklist for Laboratories

Searches such as “TB-500 Canada”, “buy TB-500 Canada”, “TB500 for sale Canada” and “BPC-157 TB-500 blend Canada” return listings that use one name for materials that are not always the same molecule. This guide is for laboratory researchers sourcing research-grade material in Canada. It explains the naming problem specific to TB-500, sets out what to check before ordering and what to ask a supplier, and describes PurixLab’s BPC-157 + TB-500 10mg blend as one option. It is a sourcing checklist for lab work, not guidance for human or veterinary use, and it makes no claims about what TB-500 does.

Start with the naming problem: TB-500, thymosin beta-4 and Ac-SDKP

Three different things are often blurred together under the TB-500 label.

  • Full-length thymosin beta-4 (Tβ4). A naturally occurring peptide of 43 amino acids [1]. It was first isolated from calf thymus, and its complete sequence was found to be identical to that of Fx, an acidic, heat-stable 5-kDa peptide that binds actin monomers in human platelets [2]. Reviews describe beta-thymosins as the main intracellular G-actin-sequestering peptides in most vertebrate cells [3].
  • TB-500 as characterised by doping-control laboratories. Analytical studies of a product sold as TB-500 identified its key ingredient as the 17-23 fragment of thymosin beta-4, LKKTETQ, carrying an acetylated N-terminus (Ac-LKKTETQ) [4,5]. That is a seven-residue peptide, not the full-length protein.
  • Ac-SDKP. A separate tetrapeptide, N-acetyl-seryl-aspartyl-lysyl-proline, that can be released from thymosin beta-4 by successive enzymatic cleavage; one study reported release by meprin-α followed by prolyl oligopeptidase [1]. It is sometimes discussed alongside Tβ4 [3], but it is a different compound again.

For a buyer the consequence is practical. A seven-residue fragment and a 43-residue protein differ greatly in mass, so “5mg of TB-500” describes a very different number of molecules depending on which one is in the vial. Ask the supplier, in writing, which sequence is supplied, whether the N-terminus is acetylated, and whether the material is the fragment or full-length thymosin beta-4. Our earlier post What is in the BPC-157 + TB-500 10mg blend covers the composition of our vial.

1. Confirm the sequence and identity by mass spectrometry

Identity is the first check, because a listing name proves nothing on its own. The published work on TB-500 shows that the expected material can be identified directly: one group detected and identified Ac-LKKTETQ in a TB-500 product by high-performance liquid chromatography with high-resolution mass spectrometry, then synthesised the peptide by solid-phase synthesis as a reference [5]. Ask for a mass-spectrometry result that reports the observed mass against the expected mass for the stated sequence, including the acetyl group. If the documentation simply says “thymosin beta-4” with no sequence, it does not tell you which molecule you are buying.

2. Ask for HPLC purity with the chromatogram

A purity percentage typed into a document proves little without the chromatogram behind it. Ask for the HPLC trace, the method used and the integration of the main peak. Peptides made by solid-phase synthesis carry predictable related impurities, including deletion and insertion sequences, racemised residues, incomplete removal of protecting groups, oxidised side chains and counter ions such as trifluoroacetate, and these can distort early functional studies [6]. For a seven-residue fragment, losing one lysine or the acetyl group produces a different peptide, and that is exactly what identity and purity data should rule out.

3. Ask which related substances and breakdown products were looked for

Ac-LKKTETQ is broken down into shorter fragments in biological matrices. Studies incubating TB-500 with human serum and liver preparations detected several metabolites [7], and a 2024 study developed a method to quantify TB-500 together with its metabolites, reporting Ac-LK as the main metabolite in rat urine and Ac-LKK as a long-lived one [8]. In that study’s fibroblast experiments, only the Ac-LKKTE fragment differed significantly from control in a wound-closure assay, and the authors suggested that activity previously attributed to TB-500 might come from that metabolite rather than the parent peptide [8].

These findings describe specific materials and conditions in published research, not any commercial vial. What they suggest is a question for your supplier: does the batch documentation check for truncated fragments of the sequence, or does it give a single purity figure with no impurity profile?

4. For a blend, ask how each component is quantified

A BPC-157 + TB-500 vial holds two different peptides. BPC-157 is a 15-residue peptide; TB-500, as described above, is a seven-residue acetylated fragment. A single “total purity” number cannot tell you whether each one is present at its labelled amount. Ask:

  • Is each peptide identified separately by mass spectrometry?
  • Does the HPLC method resolve the two peptides as separate peaks, and is each quantified against its own reference?
  • Is the labelled amount per component the peptide content, or the mass of powder weighed in?
  • Were the two components blended before or after drying, and is the ratio checked for the batch?

A supplier that cannot answer these questions leaves your stock-solution concentrations uncertain for both compounds. Our companion guide on sourcing BPC-157 in Canada covers the BPC-157 side in more detail.

5. Check the physical form, labelling and storage information

Research peptides are usually supplied as a lyophilised (freeze-dried) powder in a sealed vial. Look for a vial label that states the product name, labelled content per vial and lot number, and for written storage requirements that come from the supplier’s batch documentation rather than improvised advice. Handling should follow the label, the batch documentation and your own laboratory’s approved procedures. Be wary of listings that give usage instructions for people or animals; that is a sign the material is not being sold for laboratory research.

6. Insist on lot numbers and dates

A certificate describes only the batch it was run on. The lot number on the document should match the lot number on your vial, and the test date and the testing laboratory should be named. Detection methods developed by doping-control laboratories show how sensitively TB-500 and its metabolites can be measured [4], which is also a reminder that any result you publish should be traceable to a specific batch. Do not assume documentation exists because a listing mentions purity: ask what is available for the batch, and ask before you order.

7. Compare Canadian shipping, payment and returns

For Canadian buyers, practical questions matter as much as chemistry. Where is the stock held? Which carrier is used, and is tracking provided? Is the total in Canadian dollars, with taxes shown at checkout? What payment methods are accepted, and what happens if an order arrives damaged or incorrect? A supplier that ships domestic orders from stock held in Canada avoids the cross-border steps that can delay a shipment of temperature-sensitive material.

A short checklist

  • The listing states whether the material is the Ac-LKKTETQ fragment or full-length thymosin beta-4, and whether the N-terminus is acetylated.
  • Mass-spectrometry identity data match the expected mass for the stated sequence.
  • An HPLC chromatogram and method are available for the batch you will receive.
  • For a blend, each component is identified and quantified separately.
  • The supplier can say which truncated fragments or related impurities were checked.
  • Lot number, test date and testing laboratory appear on the document and match the vial.
  • Price, shipping cost, carrier, tracking and returns terms are stated in Canadian dollars.
  • The listing says laboratory research use only, with no instructions for people or animals and no health claims.
  • Your institution’s approvals for the project are in place.

What the literature does not settle

The analytical and metabolism studies above were carried out on specific materials, in specific matrices and models, under defined laboratory conditions. They tell you what to ask a supplier, not what any particular vial contains, and this guide does not summarise reported biological results beyond what is needed to explain the identity question. For a laboratory buyer, the practical lesson is to record exactly which molecule, which batch and which supplier each experiment used. For more on how the fragment is measured, see BPC-157 and TB-500 pharmacokinetics, metabolites and detection methods.

BPC-157 + TB-500 10mg at PurixLab

BPC-157 + TB-500 10mg: a 1:1 blend with a labelled content of BPC-157 5mg + TB-500 5mg per vial (10mg total), C$89 per vial (CAD, before tax), for laboratory research only. Product page: purixlab.com/product/bpc-157-tb-500-10mg/.

Measured against the checklist above, note that the product page lists the labelled composition and refers to batch-specific documentation for handling and storage, but it does not currently display a certificate of analysis. If your project needs particular supporting documentation, such as the sequence supplied or how each component is quantified, email [email protected] before ordering and tell us what you need; we will tell you what is available for the batch.

PurixLab ships within Canada only, from stock held in Toronto. Standard shipping is C$15, and shipping is free when the product subtotal is C$200 or more after discounts. Orders outside the GTA ship by Canada Post Xpresspost. Prices are in CAD and taxes are calculated from your shipping address at checkout.

In Toronto and the GTA, our own team delivers orders the same day or the next day. There is no fixed GTA delivery fee: after you place your order, we email you to confirm the delivery time and any delivery charge. There is no storefront or local pickup.

Payment is by Interac e-Transfer (instructions are shown at checkout). Current offers are shown on the product page and in your cart; offers do not stack.

For laboratory research use only. Not for human or veterinary use, not for consumption, injection or application to skin, and purchasers must be 18 or older. The studies summarised above describe specific materials in published research; they are not claims about any PurixLab product.

View BPC-157 + TB-500 10mg

Questions: [email protected] · Shipping & Delivery · Toronto & GTA delivery · PurixLab FAQ

References

  1. Kumar N, Nakagawa P, Janic B, et al. The anti-inflammatory peptide Ac-SDKP is released from thymosin-β4 by renal meprin-α and prolyl oligopeptidase. Am J Physiol Renal Physiol. 2016;310(10):F1026-34. PubMed 26962108 · PMC4889319 · doi:10.1152/ajprenal.00562.2015
  2. Safer D, Elzinga M, Nachmias VT. Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable. J Biol Chem. 1991;266(7):4029-32. PubMed 1999398
  3. Hannappel E. beta-Thymosins. Ann N Y Acad Sci. 2007;1112:21-37. PubMed 17468232 · doi:10.1196/annals.1415.018
  4. Ho EN, Kwok WH, Lau MY, et al. Doping control analysis of TB-500, a synthetic version of an active region of thymosin β₄, in equine urine and plasma by liquid chromatography-mass spectrometry. J Chromatogr A. 2012;1265:57-69. PubMed 23084823 · doi:10.1016/j.chroma.2012.09.043
  5. Esposito S, Deventer K, Goeman J, et al. Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. Drug Test Anal. 2012;4(9):733-8. PubMed 22962027 · doi:10.1002/dta.1402
  6. D'Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014;101:2-30. PubMed 25044089 · doi:10.1016/j.jpba.2014.06.012
  7. Esposito S, Deventer K, Geldof L, et al. In vitro models for metabolic studies of small peptide hormones in sport drug testing. J Pept Sci. 2015;21(1):1-9. PubMed 25469748 · doi:10.1002/psc.2710
  8. Rahaman KA, Muresan AR, Min H, et al. Simultaneous quantification of TB-500 and its metabolites in in-vitro experiments and rats by UHPLC-Q-Exactive orbitrap MS/MS and their screening by wound healing activities in-vitro. J Chromatogr B Analyt Technol Biomed Life Sci. 2024;1235:124033. PubMed 38382158 · doi:10.1016/j.jchromb.2024.124033

Leave a Comment

Your email address will not be published. Required fields are marked *